Tokyo, June 24 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062018) titled 'Asian Vibration-Controlled Transient Elastography registry study' on June 23.
Study Type:
Observational
Primary Sponsor:
Institute - JSG-NAFLD
Condition:
Condition - Nonalcoholic fatty liver disease (NAFLD), which is now known as metabolic dysfunction-associated steatotic liver disease (MASLD).
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - This study was designed to clarify the impact of comorbidities and their corresponding medications on overall prognosis in patients with steatotic liver disease who underwent liver stiffness measurement, using data from a multicenter registry.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 20
years-old
=20 years at the time of the initial liver stiffness measurement (enrollment).
Key exclusion criteria - 1. Patients deemed unsuitable for participation in this study by the investigator.
2. Patients who declined participation in the study.
3. Patients suspected of having concomitant chronic liver diseases other than steatotic liver disease.
Target Size - 6000
Recruitment Status:
Recruitment status - No longer recruiting
Date of protocol fixation - 2023 Year 02 Month 02 Day
Date of IRB - 2023 Year 03 Month 24 Day
Anticipated trial start date - 2023 Year 04 Month 01 Day
Last follow-up date - 2026 Year 06 Month 30 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070966
Disclaimer: Curated by HT Syndication.
